News + Filings Transactions
|
GV 2019 GP, L.L.C.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/08/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 5k | $0.00 | $0 | By GV 2019, L.P. | 06/07/2023 |
06/08/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 5k | $15.74 | $78.7k | By Alphabet Holdings LLC | 06/07/2023 |
06/07/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 15k | $0.00 | $0 | By GV 2019, L.P. | 06/07/2023 |
06/07/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 15k | $16.92 | $253.9k | By Alphabet Holdings LLC | 06/07/2023 |
06/06/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 30k | $0.00 | $0 | By GV 2019, L.P. | 06/05/2023 |
06/06/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 30k | $17.02 | $510.2k | By Alphabet Holdings LLC | 06/05/2023 |
06/05/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 22.4k | $0.00 | $0 | By GV 2019, L.P. | 06/05/2023 |
06/05/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 22.4k | $16.70 | $374.6k | By Alphabet Holdings LLC | 06/05/2023 |
05/30/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 16.8k | $0.00 | $0 | By GV 2019, L.P. | 05/26/2023 |
05/30/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 16.8k | $13.70 | $230.2k | By Alphabet Holdings LLC | 05/26/2023 |
05/26/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 12.6k | $0.00 | $0 | By GV 2019, L.P. | 05/26/2023 |
05/26/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 12.6k | $13.70 | $172.6k | By Alphabet Holdings LLC | 05/26/2023 |
05/25/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 23.2k | $0.00 | $0 | By GV 2019, L.P. | 05/24/2023 |
05/25/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 23.2k | $13.38 | $310k | By Alphabet Holdings LLC | 05/24/2023 |
05/24/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 7.9k | $0.00 | $0 | By GV 2019, L.P. | 05/24/2023 |
05/24/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 7.9k | $13.66 | $107.9k | By Alphabet Holdings LLC | 05/24/2023 |
05/23/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 43.9k | $0.00 | $0 | By GV 2019, L.P. | 05/22/2023 |
05/23/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 43.9k | $14.74 | $647.6k | By Alphabet Holdings LLC | 05/22/2023 |
05/22/2023 | Prime Medicine, Inc. | | Other (disposition) | Common Stock | 87.9k | $0.00 | $0 | By GV 2019, L.P. | 05/22/2023 |
05/22/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 87.9k | $14.13 | $1.2M | By Alphabet Holdings LLC | 05/22/2023 |
05/17/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 15k | $12.77 | $191.6k | By GV 2019, L.P. | 05/16/2023 |
05/16/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 50.6k | $12.59 | $637.7k | By GV 2019, L.P. | 05/16/2023 |
05/15/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 158k | $12.74 | $2M | By GV 2019, L.P. | 05/12/2023 |
05/12/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 27.3k | $12.72 | $347.2k | By GV 2019, L.P. | 05/12/2023 |
05/11/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 21.8k | $12.98 | $283.2k | By GV 2019, L.P. | 05/10/2023 |
05/11/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 4.8k | $13.79 | $66.3k | By GV 2019, L.P. | 05/10/2023 |
05/10/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 87.4k | $14.03 | $1.2M | By GV 2019, L.P. | 05/10/2023 |
05/09/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 321.2k | $14.08 | $4.5M | By GV 2019, L.P. | 05/08/2023 |
05/08/2023 | Prime Medicine, Inc. | | Sale | Common Stock | 100.8k | $14.13 | $1.4M | By GV 2019, L.P. | 05/08/2023 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 4M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Common Stock | 443.3k | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series A-2 Preferred Stock | 37.3M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
06/21/2021 | Verve Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 4.1M | $0.00 | $0 | By GV 2019 L.P. | 06/21/2021 |
02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Common Stock | 819.6k | $0.00 | $0 | By GV 2019, L.P. | 02/17/2021 |
02/17/2021 | Decibel Therapeutics, Inc. | DBTX | Conversion | Series D Preferred Stock | 4.3M | $0.00 | $0 | By GV 2019, L.P. | 02/17/2021 |
|